Muctarr Sesay PhD

Muctarr Sesay, PhD is the Chief Scientific Officer and Vice President of Bioconjugation Development at Goodwin Biotechnology. Dr. Sesay has over 20 years of industrial experience in bioconjugation and modification of biological molecules and small molecules, and over 15 years of experience in the biotechnology sectors. Prior to joining Goodwin in 2002, Dr. Sesay supervised many projects in R&D, Process Development, and manufacturing of biologics at Life Technologies (now Thermo-Fisher), Kirkegaard and Perry Laboratories (KPL), and Elusys Therapeutics. After receiving his PhD in Biochemistry from the University of London, England, Dr. Sesay worked for about 3 years as a postdoctoral candidate at the University of Maryland, College Park in Protein Purification and Characterization.